Quasi-drug price labelling system to postpone 6 more months.

Published: 2001-01-15 15:52:00

Updated: 2001-01-15 15:52:00

The price labelling system applicable to all quasi-drugs as originally planned to implement from Jan. 1 this year has put off until coming June, considering a full probation period for manufacturers to consume all stocks and to prepare new package requirements.

The MOHW made it clear in the pa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK